Persistent COVID-19: Clinical Trials

6 trials for Persistent COVID-19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 recruiting. 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 1, Unknown 1
Phase 22Completed 2

Follow Persistent COVID-19: new trials by email Literature Review of Persistent COVID-19 trials Research Report on Persistent COVID-19

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)
Plitidepsin 1.5 mg/day, Placebo, Placebo and Plitidepsin 1.5mg/day - Post COVID-19 Condition, Long COVID Syndrome
Phase 2CompletedFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia902025-02-072026-10-08
Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients
Persisting SARS-CoV-2 infection - Persistent COVID-19, B Cell Malignancies
CompletedMaddalena Giannella2042024-03-012026-05-28
Efficacy of Two Therapeutic Exercise Modalities for Patients With Persistent COVID
exercise programe - Persistent COVID-19
Not applicableUnknownFacultat de ciencies de la Salut Universitat Ramon Llull402023-06-012023-11-21
Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.
Transcranial Direct Current Therapy (tDCS), Sham (No Treatment) - COVID-19, Long COVID
Not applicableRecruitingFundación Universidad Católica de Valencia San Vicente Mártir872023-04-012026-10-15
Vascular Structure, Vascular Function and Vascular Aging in Adults Diagnosed With Persistent COVID
Persistent COVID-19, Quality of Life
UnknownFundacion para la Investigacion y Formacion en Ciencias de la Salud3002023-03-092023-06-29
The Use of Photobiomodulation in the Treatment of Oral Complaints of Long COVID-19.A Randomized Controlled Trial.
Institutional standard treatment for xerostomia and Long Covid, Photobiomodulation Therapy, Placebo Photobiomodulation Therapy - Xerostomia, COVID-19
Phase 2CompletedUniversity of Nove de Julho102023-03-012024-03-12

Narrower conditions

Post-Acute COVID-19 Syndrome (6)  ·  COVID-19 (4)  ·  Arthralgia (1)  ·  Chronic Pain (1)  ·  Cluster Headache (1)  ·  Headache Disorders (1)  ·  Migraine Disorders (1)  ·  Myalgia (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Xerostomia (1)

Broader conditions

Chronic Disease (6)  ·  Coronaviridae Infections (6)  ·  Coronavirus Infections (6)  ·  Disease Attributes (6)  ·  Infections (6)  ·  Lung Diseases (6)  ·  Nidovirales Infections (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Pneumonia (6)  ·  Pneumonia, Viral (6)  ·  Post-Infectious Disorders (6)  ·  RNA Virus Infections (6)  ·  Respiratory Tract Diseases (6)  ·  Respiratory Tract Infections (6)

Interventions

Low-Level Light Therapy (1)  ·  Transcranial Direct Current Stimulation (1)  ·  plitidepsin (1)

Sponsors

Facultat de ciencies de la Salut Universitat Ramon Llull (1)  ·  Fundacion para la Investigacion y Formacion en Ciencias de la Salud (1)  ·  Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1)  ·  Fundación Universidad Católica de Valencia San Vicente Mártir (1)  ·  Maddalena Giannella (1)  ·  University of Nove de Julho (1)

Countries

Spain (5)  ·  Brazil (1)  ·  Italy (1)

Top investigators

Maddalena Giannella, MD PhD (1)  ·  Rebeca B Cecatto, M.D., Ph.D. (1)

Results publications

PMID 35059791, PMID 37772064, PMID 38344236, PMID 41683236